- Home
- SNBR vs FHTX Comparison
SNBR vs FHTX Comparison
Compare SNBR & FHTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SNBR
- FHTX
- Stock Information
- Founded
- SNBR 1987
- FHTX 2015
- Country
- SNBR United States
- FHTX United States
- Employees
- SNBR N/A
- FHTX N/A
- Industry
- SNBR Home Furnishings
- FHTX Medicinal Chemicals and Botanical Products
- Sector
- SNBR Consumer Discretionary
- FHTX Health Care
- Exchange
- SNBR Nasdaq
- FHTX Nasdaq
- Market Cap
- SNBR 154.1M
- FHTX 271.5M
- IPO Year
- SNBR 1998
- FHTX 2020
- Fundamental
- Price
- SNBR $7.44
- FHTX $5.40
- Analyst Decision
- SNBR Hold
- FHTX Strong Buy
- Analyst Count
- SNBR 2
- FHTX 8
- Target Price
- SNBR $9.00
- FHTX $12.63
- AVG Volume (30 Days)
- SNBR 502.1K
- FHTX 144.3K
- Earning Date
- SNBR 07-30-2025
- FHTX 08-07-2025
- Dividend Yield
- SNBR N/A
- FHTX N/A
- EPS Growth
- SNBR N/A
- FHTX N/A
- EPS
- SNBR N/A
- FHTX N/A
- Revenue
- SNBR $1,605,108,000.00
- FHTX $23,504,000.00
- Revenue This Year
- SNBR N/A
- FHTX $44.01
- Revenue Next Year
- SNBR $4.27
- FHTX $9.45
- P/E Ratio
- SNBR N/A
- FHTX N/A
- Revenue Growth
- SNBR N/A
- FHTX N/A
- 52 Week Low
- SNBR $4.48
- FHTX $2.95
- 52 Week High
- SNBR $20.75
- FHTX $10.25
- Technical
- Relative Strength Index (RSI)
- SNBR 46.45
- FHTX 64.55
- Support Level
- SNBR $7.44
- FHTX $4.78
- Resistance Level
- SNBR $8.44
- FHTX $5.52
- Average True Range (ATR)
- SNBR 0.61
- FHTX 0.32
- MACD
- SNBR 0.11
- FHTX 0.05
- Stochastic Oscillator
- SNBR 53.61
- FHTX 86.67
About SNBR Sleep Number Corporation
Sleep Number Corp. is a wellness technology company engaged in the design, manufacturing, marketing and distribution of sleep solutions. The Company generates revenue by marketing and selling its smart beds directly to new and existing customers through its vertically integrated, exclusive, direct-to-consumer retail touch points including Stores, Online, Phone, and Chat (Total Retail). The products offered by the company are Mattresses, Bedding, Pillows and Furniture.
About FHTX Foghorn Therapeutics Inc.
Foghorn Therapeutics Inc is engaged in the discovery and development of a new class of medicines targeting genetically determined dependencies within the chromatin regulatory system. Its proprietary Gene Traffic Control platform gives an integrated, mechanistic understanding of how the various components of the chromatin regulatory system interact, allowing it to identify, validate, and potentially drug targets within the system. The company is developing FHD-286, a selective, allosteric ATPase inhibitor, and FHD-609, a protein degrader, to treat hematologic cancers and solid tumors.